Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective
IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits. GLP-1 RAs have been used for diabetes and found to improve CV outcomes in diabetic and nondiabetic patients. They are authorized for treating obesity. Our narrative review disc...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2025-04-01
|
| Serie: | Frontiers in Cardiovascular Medicine |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1535134/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|